Bitcoin News Update: Propanc’s Cryptocurrency-Driven Cancer Initiative Encounters Doubt from Investors, Stock Falls by 10.5%
- Australia-based Propanc Biopharma secured up to $100M from Hexstone Capital to build a crypto treasury and advance its cancer therapy PRP, targeting first-in-human trials by 2026. - The funding strategy reflects a growing trend in biotech to leverage crypto assets for non-dilutive capital, with Hexstone’s portfolio including Bitcoin , Ether , and Solana . - CEO James Nathanielsz called the move "transformative," aiming to diversify Propanc’s assets while tying capital to clinical milestones, though share
Headquartered in Australia,
This financing approach mirrors a rising trend among biotech companies turning to crypto treasuries as traditional capital markets become more challenging. Firms such as Sonnet BioTherapeutics and Sharps Technology have also embraced digital asset strategies to attract investors and diversify their funding streams
Hexstone Capital, which has supported other crypto treasury projects, has not specified which digital assets Propanc intends to purchase. Still, its holdings include Bitcoin (BTC), Ether (ETH),
The broader landscape for crypto treasury firms has encountered difficulties, with companies like Strategy and Metaplanet seeing notable drops in market capitalization
Propanc’s combined focus on cancer research and digital assets places it at the crossroads of two rapidly expanding industries. Preclinical studies of PRP have demonstrated a 70% reduction in tumor size in animal tests
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
XRP News Today: XRP as a Gateway to Trillion-Dollar Transactions: Will It Surpass BTC and ETH?
- XRP's rally depends on breaking $2.40–$2.45 resistance against BTC/ETH to outperform major cryptocurrencies. - Institutional integrations and post-SEC clarity boost XRP's utility in cross-border payments and custody solutions. - Rising realized gains and profit-taking pressure challenge near-term optimism despite 30% YoY ledger volume growth. - ETF approval could inject $1B liquidity, but sustained momentum requires overcoming historical resistance clusters.

Cardano News Update: The 2025 Crypto Battle—AI-Fueled Hype Versus Widespread Acceptance
- Blazpay and Cardano lead 2025 crypto race with AI tools and real-world adoption strategies, outpacing Avalanche. - Blazpay's $843,700 presale targets speculative investors via AI-powered multichain platform with 800,000+ users. - Cardano partners with Wirex to launch Visa-compatible crypto cards, aiming to bridge TradFi and blockchain ecosystems. - Divergent approaches highlight industry split between high-risk AI speculation and practical crypto integration for mass adoption.

Resilient and Profitable: Top 3 Meme Coins Proving Their Strength Amid the Market Sell-Off

PENGU Bulls Return With Breakout Hopes Above $0.017
